{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:57:29Z","timestamp":1790611049376,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.beem.2026.102160","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T16:09:05Z","timestamp":1787155745000},"page":"102160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ophthalmic assessment in endocrine disease"],"prefix":"10.1016","volume":"40","author":[{"given":"Lawrence","family":"Langley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Kirkpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2026.102160_bib1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1093\/qjmed\/77.2.1151","article-title":"Clinical features and natural history of von Hippel-Lindau disease","volume":"77","author":"Maher","year":"1990","journal-title":"Q J Med"},{"key":"10.1016\/j.beem.2026.102160_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2025.100846","article-title":"Risk analysis of retinal hemangioblastomas in nonadvanced stages of von Hippel-Lindau syndrome using ultra-widefield imaging: the ULTRA von Hippel-Lindau study","volume":"5","author":"Del Fabbro","year":"2025","journal-title":"Ophthalmol Sci"},{"key":"10.1016\/j.beem.2026.102160_bib3","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.1957169","article-title":"Optical coherence tomography","volume":"254","author":"Huang","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.beem.2026.102160_bib4","article-title":"Corneal parameters, ocular biometers, and retinal and choroidal thickness in acromegaly patients","volume":"44","author":"Batur","year":"2023","journal-title":"Photo Photodyn Ther"},{"key":"10.1016\/j.beem.2026.102160_bib5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/ICO.0000000000000297","article-title":"Topographic and biomechanical evaluation of cornea in patients with acromegaly","volume":"34","author":"Altinkaynak","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.beem.2026.102160_bib6","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1080\/08820538.2018.1519582","article-title":"Refractive changes associated with diabetes mellitus","volume":"33","author":"Kastelan","year":"2018","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2022.02.001","article-title":"Ocular surface disease in thyroid eye disease: a narrative review","volume":"24","author":"Rana","year":"2022","journal-title":"Ocul Surf"},{"key":"10.1016\/j.beem.2026.102160_bib8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1177\/1352458517690822","article-title":"Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis","volume":"23","author":"Balcer","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/j.beem.2026.102160_bib9","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000154521.40686.63","article-title":"Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis","volume":"64","author":"Baier","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.beem.2026.102160_bib10","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/WNO.0000000000000662","article-title":"Evolution of visual outcomes in clinical trials for multiple sclerosis disease-modifying therapies","volume":"38","author":"Nolan","year":"2018","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib11","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/archopht.120.6.701","article-title":"The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma","volume":"120","author":"Kass","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib12","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-0029-1245199","article-title":"Pathophysiology of intraocular pressure increase and glaucoma prevalence in thyroid eye disease: a mini-review","volume":"227","author":"Haefliger","year":"2010","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.beem.2026.102160_bib13","first-page":"522","article-title":"Preliminary study on the correlation between episcleral venous pressure and intraocular pressure in TAO patients and its clinical value","volume":"30","author":"Fan","year":"2024","journal-title":"Altern Ther Health Med"},{"key":"10.1016\/j.beem.2026.102160_bib14","first-page":"162","article-title":"Upgaze intraocular pressure changes and strabismus in Graves' ophthalmopathy","volume":"11","author":"Fishman","year":"1991","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib15","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0161-6420(91)32100-6","article-title":"The role of increased intraocular pressure on upgaze in the assessment of Graves ophthalmopathy","volume":"98","author":"Spierer","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.beem.2026.102160_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000328630","article-title":"Steroid-induced iatrogenic glaucoma","volume":"47","author":"Razeghinejad","year":"2012","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.beem.2026.102160_bib17","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1177\/1120672119885050","article-title":"Risk of intraocular pressure elevation after topical steroids in children and adults: a systematic review","volume":"30","author":"Musleh","year":"2020","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib18","article-title":"Endogenous hypercortisolism inducing reversible ocular hypertension","volume":"16","author":"Griffin","year":"2019","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/j.beem.2026.102160_bib19","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/IJG.0000000000002113","article-title":"Increased risk of ocular hypertension in patients with Cushing's disease","volume":"31","author":"Ma","year":"2022","journal-title":"J Glaucoma"},{"key":"10.1016\/j.beem.2026.102160_bib20","article-title":"Die St\u00f6rungen des Farbensinnes: ihre klinische Bedeutung und ihre Diagnose","author":"K\u00f6llner","year":"1912","journal-title":"Berl S Karger"},{"key":"10.1016\/j.beem.2026.102160_bib21","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/bjo.2006.094607","article-title":"Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey","volume":"91","author":"McKeag","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1364\/JOSAA.29.000313","article-title":"Worldwide prevalence of red-green color deficiency","volume":"29","author":"Birch","year":"2012","journal-title":"J Opt Soc Am A Opt Image Sci Vis"},{"key":"10.1016\/j.beem.2026.102160_bib23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/jfmpc.jfmpc_1298_21","article-title":"RAPD as a clinical alert for early evidence of dysthyroid optic neuropathy","volume":"11","author":"Gupta","year":"2022","journal-title":"J Fam Med Prim Care"},{"key":"10.1016\/j.beem.2026.102160_bib24","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/practneurol-2015-001155","article-title":"How to interpret visual fields","volume":"15","author":"Wong","year":"2015","journal-title":"Pract Neurol"},{"key":"10.1016\/j.beem.2026.102160_bib25","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1212\/WNL.0b013e3181d90017","article-title":"Diagnostic accuracy of confrontation visual field tests","volume":"74","author":"Kerr","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.beem.2026.102160_bib26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11102-018-0906-2","article-title":"Optical coherence tomography retinal ganglion cell complex analysis for the detection of early chiasmal compression","volume":"21","author":"Blanch","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/j.beem.2026.102160_bib27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10143-023-01990-w","article-title":"Optical coherence tomography detects early optic nerve damage before visual field defect in patients with pituitary tumors","volume":"46","author":"Sasagawa","year":"2023","journal-title":"Neurosurg Rev"},{"key":"10.1016\/j.beem.2026.102160_bib28","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' Orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2026.102160_bib29","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1136\/bjo.2008.154195","article-title":"Is 6 months of stable angle of strabismus enough to perform surgery in patients with strabismus related to thyroid ophthalmopathy?","volume":"94","author":"Lee","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib30","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.beem.2026.102160_bib31","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/jamaophthalmol.2021.6284","article-title":"Proptosis and diplopia response with teprotumumab and placebo vs the recommended treatment regimen with intravenous methylprednisolone in moderate to severe thyroid eye disease: a meta-analysis and matching-adjusted indirect comparison","volume":"140","author":"Douglas","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib32","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.jocn.2006.07.016","article-title":"Cranial nerve palsies accompanying pituitary tumour","volume":"14","author":"Kim","year":"2007","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.beem.2026.102160_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105969","article-title":"Isolated third cranial nerve palsy in pituitary apoplexy: case report and systematic review","volume":"30","author":"Rosso","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.beem.2026.102160_bib34","doi-asserted-by":"crossref","first-page":"G12","DOI":"10.1530\/EC-16-0057","article-title":"Society for Endocrinology endocrine emergency guidance: emergency management of pituitary apoplexy in adult patients","volume":"5","author":"Baldeweg","year":"2016","journal-title":"Endocr Connect"},{"key":"10.1016\/j.beem.2026.102160_bib35","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1136\/bjo.2008.155150","article-title":"Pain in ischaemic ocular motor cranial nerve palsies","volume":"93","author":"Wilker","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/01658107.2014.963252","article-title":"Microvascular non-arteritic ocular motor nerve palsies \u2014 what we know and how should we treat?","volume":"39","author":"Galtrey","year":"2015","journal-title":"Neuroophthalmology"},{"key":"10.1016\/j.beem.2026.102160_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaophthalmol.2016.4456","article-title":"Incidence and etiologies of acquired third nerve palsy using a population-based method","volume":"135","author":"Fang","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib38","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0002-9394(14)70276-4","article-title":"Clinical features of Graves' ophthalmopathy in an incidence cohort","volume":"121","author":"Bartley","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach","volume":"73","author":"Mourits","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib40","doi-asserted-by":"crossref","first-page":"T29","DOI":"10.1530\/ERC-17-0209","article-title":"A comprehensive review on MEN2B","volume":"25","author":"Castinetti","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.beem.2026.102160_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s004170000245","article-title":"Typical ocular findings in a patient with multiple endocrine neoplasia type 2b syndrome","volume":"239","author":"Eter","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib42","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0002-9394(00)00539-0","article-title":"Stages of improvement in visual fields after pituitary tumor resection","volume":"130","author":"Kerrison","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib43","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1167\/iovs.07-1127","article-title":"vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors","volume":"49","author":"Danesh-Meyer","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.beem.2026.102160_bib44","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/aos.12515","article-title":"Toxic optic neuropathies: an updated review","volume":"93","author":"Grzybowski","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.beem.2026.102160_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14895","article-title":"Progress and recognition of idiopathic intracranial hypertension: a narrative review","volume":"30","author":"Zhou","year":"2024","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.beem.2026.102160_bib46","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41582-023-00893-0","article-title":"Idiopathic intracranial hypertension: a step change in understanding the disease mechanisms","volume":"19","author":"Yiangou","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.beem.2026.102160_bib47","article-title":"A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics","volume":"4","author":"O'Reilly","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.beem.2026.102160_bib48","doi-asserted-by":"crossref","first-page":"c2701","DOI":"10.1136\/bmj.c2701","article-title":"Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study","volume":"341","author":"Sinclair","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.beem.2026.102160_bib49","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1136\/jnnp-2017-317440","article-title":"Idiopathic intracranial hypertension: consensus guidelines on management","volume":"89","author":"Mollan","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X26000825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:20:08Z","timestamp":1790608808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X26000825"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1521690X26000825"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2026.102160","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ophthalmic assessment in endocrine disease","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2026.102160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102160"}}